Myokine Circulating Levels in Postmenopausal Women with Overweight or Obesity: Effects of Resistance Training and/or DHA-Rich -3 PUFA Supplementation.

Alejandro Martínez-Gayo, Javier Ibáñez-Santos, Elisa Félix-Soriano, María J Moreno-Aliaga, Marisol García-Unciti, Pedro González-Muniesa

Journal: Nutrients 2025;17(15):

PMID: 40806137

Abstract

BACKGROUND

Menopause increases the risk of cardiovascular diseases (CVD) accompanied by a decline in muscle function. Myokines, released by skeletal muscle, could play a significant role in cardiovascular health.

OBJECTIVES AND METHODS

This study aimed to investigate the changes induced by a 16-week resistance training (RT) program and/or the docosahexaenoic acid (DHA)-rich -3 PUFA supplementation on myokine and cytokine circulating levels and to study their associations with parameters of body composition, muscle function, and glucose and lipid serum markers in postmenopausal women with overweight/obesity.

RESULTS

At baseline, interleukin-6 (IL-6) levels were positively correlated with body fat and with tumor necrosis factor-alpha (TNF-α) levels and negatively associated with meterorin-like (METRNL) levels. Moreover, METRNL was inversely associated with insulin levels and with HOMA-IR. After the intervention, muscle quality improved with either treatment but more notably in response to RT. -3 supplementation caused significant improvements in cardiometabolic health markers. TNF-α decreased in all experimental groups. Myostatin levels decreased in the RT and in the -3 groups, and IL-6 increased in the -3+RT group. Lastly, no interactions between treatments were observed.

CONCLUSIONS

In postmenopausal women with overweight or obesity, RT could help improve skeletal muscle function, while DHA-rich -3 supplementation might decrease CVD risk and might potentially improve muscle function. The modulation of myokine levels could be underlying some of the effects of DHA or RT; however, further research is necessary.

Address: Department of Nutrition, Food Sciences and Physiology, Centre for Nutrition Research, Faculty of Pharmacy and Nutrition, University of Navarra, 31008 Pamplona, Spain.; Studies, Research and Sports Medicine Centre (CEIMD), Government of Navarre, 31005 Pamplona, Spain.; Department of Nutrition, Food Sciences and Physiology, Centre for Nutrition Research, Faculty of Pharmacy and Nutrition, University of Navarra, 31008 Pamplona, Spain.; IdISNA, Navarra Institute for Health Research, 31008 Pamplona, Spain.; Department of Nutrition, Food Sciences and Physiology, Centre for Nutrition Research, Faculty of Pharmacy and Nutrition, University of Navarra, 31008 Pamplona, Spain.; IdISNA, Navarra Institute for Health Research, 31008 Pamplona, Spain.; CIBER Physiopathology of Obesity and Nutrition (CIBEROBN), Carlos III Health Institute (ISCIII), 28029 Madrid, Spain.
Bant logo

© Copyright 2026, Nutrition Evidence

NED wishes to thank the following organisations for their support:

We use cookies to improve your experience and analyze site traffic with Google Analytics. By continuing to use our site, you agree to our use of cookies. Learn more.